Tempus AI, Inc. (TEM)
Analyzes patient genetic and medical data to guide cancer treatment decisions.
$41.81-0.03%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-24.4%
The outlook
Tempus AI trades near its 52-week low, well below both its 50- and 200-day moving averages, signaling a weakened recent trend. Analysts lean bullish with a "Buy" consensus and an average price target roughly 59% above the current level. The overall picture reflects a stock under pressure despite optimistic analyst sentiment.
What’s behind the score
Analyst consensusBuy — 2.2 avg of 14 analysts
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Price targetAvg target +59% vs current price
Analyst price target
~12-month · 14 analysts$66.57average target+59.2% vs now
Now $41.81
Low $35.00High $100.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$7.53B
52-wk high
$104.32
52-wk low
$41.73
50-day avg
$51.15
200-day avg
$60.50
Trailing P/E
—